Now showing items 1-4 of 4

    • Fink, Valeria I.; Shepherd, Bryan E.; Cesar, Carina; Krolewiecki, Alejandro; Wehbe, Firas; Cortés, Claudia P.; Ramírez, Brenda Crabtree; Padgett, Denis; Shafaee, Maryam; Schechter, Mauro; Gotuzzo, Eduardo; Bacon, Melanie; McGowan, Catherine C.; Cahn, Pedro; Masys, Daniel (2011)
      Background: HIV-infected individuals have heightened cancer risk. With the advent of highly active antiretroviral therapy (HAART), the frequency of some AIDS-defining cancers (ADC) has decreased although certain non-AIDS-defining ...
    • Mcgowan, Catherine C.; Cahn, Pedro; Gotuzzo, Eduardo; Padgett, Denis; Pape, Jean W.; Wolff Reyes, Marcelo; Schechter, Mauro; Masys, Daniel R. (2007)
    • Tuboi, Suely H.; Schechter, Mauro; McGowan, Catherine C.; Cesar, Carina; Krolewiecki, Alejandro; Cahn, Pedro; Wolff Reyes, Marcelo; Pape, Jean W.; Padgett, Denis; Madero, Juan Sierra; Gotuzzo, Eduardo; Masys, Daniel R.; Shepherd, Bryan E. (Lippincott Williams and Wilkins, 2009)
      BACKGROUND:: Although nearly 2 million people live with HIV in Latin America and the Caribbean, mortality rates after initiation of highly active antiretroviral therapy (HAART) have not been well described. METHODS:: Five ...
    • Cesar, Carina; Shepherd, Bryan E.; Krolewiecki, Alejandro J.; Fink, Valeria I.; Schechter, Mauro; Tuboi, Suely H.; Wolff Reyes, Marcelo; Pape, Jean W.; Leger, Paul; Padgett, Denis; Madero, Juan Sierra; Gotuzzo, Eduardo; Sued, Omar; Mcgowan, Catherine C.; Masys, Daniel R.; Cah (2010)
      Background: HAART rollout in Latin America and the Caribbean has increased from approximately 210,000 in 2003 to 390,000 patients in 2007, covering 62% (51%-70%) of eligible patients, with considerable variation among ...